NewGenIvf Announces Pricing of $1.25 Million Public Offering
NewGenIvf Group (NIVF) has announced the pricing of a public offering expected to raise approximately $1.25 million in gross proceeds before fees and expenses. The company plans to issue up to 17.86 million ordinary shares or pre-funded warrants at a price of $0.07 per share. This fundraising effort is intended to support the company's operations, though specific use-of-proceeds details were not disclosed in the announcement. As with many small-cap biotech firms, such offerings are often used for general corporate purposes and may signal strategic moves or capital needs ahead of clinical developments or regulatory milestones.
Tickers: $NIVF